SSTR4 agonist therapy(Confo Therapeutics)

N/A

Report date: 2024/08/28 16:26:44
NME

Base Information

Drug NameSSTR4 agonist therapy(Confo Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 4 agonists
TargetsSomatostatin receptor 4
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConfo Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesConfo Therapeutics NV
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A